Presidio Management Group X LLC - 20 Jul 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role: 10%+ Owner
Signature: Dale Holladay, Attorney in Fact for each Reporting Person
Issuer symbol: EFTR on OTC
Transactions as of: 20 Jul 2022
Net transactions value: -$19,514
Form type: 4
Filing time: 22 Jul 2022, 18:03:17 UTC
Previous filing: 19 Jul 2022
Next filing: 27 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EFTR	Common Stock	Sale	$9,736	-9,726	-0.23%	$1.00	4,181,509	20 Jul 2022	Directly owned by USVP X	F1, F2
transaction	EFTR	Common Stock	Sale	$304	-304	-0.23%	$1.00	133,795	20 Jul 2022	Directly owned by AFF X	F1, F2
transaction	EFTR	Common Stock	Sale	$2,468	-2,584	-0.06%	$0.9550	4,178,925	21 Jul 2022	Directly owned by USVP X	F1, F2
transaction	EFTR	Common Stock	Sale	$77.44	-81	-0.06%	$0.9560	133,714	21 Jul 2022	Directly owned by AFF X	F1, F2
transaction	EFTR	Common Stock	Sale	$6,719	-7,383	-0.18%	$0.9100	4,171,542	22 Jul 2022	Directly owned by USVP X	F1, F2
transaction	EFTR	Common Stock	Sale	$210	-231	-0.17%	$0.9110	133,483	22 Jul 2022	Directly owned by AFF X	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.02, inclusive for sales on 7/20/22; prices ranging from $0.94 to $1.00, inclusive for sales on 7/21/22; and prices ranging from $0.91 to $0.94, inclusive for sales on 7/22/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F2	Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.02, inclusive for sales on 7/20/22; prices ranging from $0.94 to $1.00, inclusive for sales on 7/21/22; and prices ranging from $0.91 to $0.94, inclusive for sales on 7/22/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.